To investigate whether HIF-2α overexpression impacts the drug sensitivity of breast cancer cells to PTX, we treated HIF-2α-overexpressing MCF7 and MDA-MB-231 cells with different concentrations of PTX for 48 h and examined changes in cell viability. The gene discussed is EPAS1; the disease is breast cancer.